Atenolol versus Losartan in Marfan's Syndrome

N Engl J Med. 2015 Mar 5;372(10):977-8. doi: 10.1056/NEJMc1500128.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Aorta / drug effects*
  • Aortic Aneurysm / prevention & control*
  • Atenolol / therapeutic use*
  • Female
  • Humans
  • Losartan / therapeutic use*
  • Male
  • Marfan Syndrome / drug therapy*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Atenolol
  • Losartan